Literature DB >> 27680545

[Drug therapy of otorhinolaryngological diseases in pregnancy : An update].

R Riepl1, U Friebe-Hoffmann2.   

Abstract

The majority of women take at least one form of medication during pregnancy. Due to often discrepant information about the risk assessment of pharmaceuticals during pregnancy, physicians are often beset by uncertainty with respect to prescription and the fear of medicolegal consequences is high. As prospective clinical trials on drug safety during pregnancy are prohibited due to ethical reasons and animal studies are of limited applicability to humans, drug recommendations often only rely on observational data. An objective examination of the topic not only contributes to effective treatment of illnesses in pregnancy but also prevents impairment of fetal outcome by omission of necessary maternal treatment. The aim of this article is to give a structured presentation of medications that can be used during pregnancy for treating medical conditions of the ear, nose and throat, in the sense of practical guidelines.

Entities:  

Keywords:  Fetotoxicity; Medication; Off label use; Pregnancy; Teratogens

Mesh:

Year:  2016        PMID: 27680545     DOI: 10.1007/s00106-016-0236-5

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  19 in total

1.  [Medication therapy during pregnancy].

Authors:  S Gronau; A Neumann
Journal:  HNO       Date:  2012-07       Impact factor: 1.284

2.  A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4.

Authors:  Lu Gaohua; Khaled Abduljalil; Masoud Jamei; Trevor N Johnson; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

Review 3.  A Review of Antibiotic Use in Pregnancy.

Authors:  P Brandon Bookstaver; Christopher M Bland; Brooke Griffin; Kayla R Stover; Lea S Eiland; Milena McLaughlin
Journal:  Pharmacotherapy       Date:  2015-11       Impact factor: 4.705

4.  Drug use in pregnancy: an overview of epidemiological (drug utilization) studies.

Authors:  M Bonati; R Bortolus; F Marchetti; M Romero; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 5.  A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide.

Authors:  Paul A Gluck; Joan C Gluck
Journal:  Curr Med Res Opin       Date:  2005-07       Impact factor: 2.580

Review 6.  Pharmacokinetics and Pharmacodynamics of Drugs Commonly Used in Pregnancy and Parturition.

Authors:  Jessica Ansari; Brendan Carvalho; Steven L Shafer; Pamela Flood
Journal:  Anesth Analg       Date:  2016-03       Impact factor: 5.108

7.  Use of dipyrone during pregnancy and risk of Wilms' tumor. Brazilian Wilms' Tumor Study Group.

Authors:  C R Sharpe; E L Franco
Journal:  Epidemiology       Date:  1996-09       Impact factor: 4.822

8.  Therapeutic drug use during pregnancy: a comparison in four European countries. OECM Working Group. Occupational Exposures and Congenital Anomalies.

Authors:  C De Vigan; H E De Walle; S Cordier; J Goujard; R Knill-Jones; S Aymé; E Calzolari; F Bianchi
Journal:  J Clin Epidemiol       Date:  1999-10       Impact factor: 6.437

Review 9.  Management of rhinosinusitis during pregnancy: systematic review and expert panel recommendations.

Authors:  Devyani Lal; Ameya A Jategaonkar; Larry Borish; Linda R Chambliss; Sharon H Gnagi; Peter H Hwang; Matthew A Rank; James A Stankiewicz; Valerie J Lund
Journal:  Rhinology       Date:  2016-06       Impact factor: 3.681

10.  Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children.

Authors:  J Headley; K Northstone; H Simmons; J Golding
Journal:  Eur J Clin Pharmacol       Date:  2004-05-28       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.